America is reliant on mainland companies for the raw materials needed to make life-saving drugs, but experts say duties are likely Chinese drug makers could face squeezed profit margins, as US ...

Americans spend more on prescription and over-the-counter drugs than anyone else in the world. It’s true that they take a lot ...

UnitedHealth's stock has tumbled 45.8% in 2025, enough to make it the S&P 500's worst performer this year. In comparison, the Health Care Select Sector SPDR ETF XLV has lost 5.2% this year and the S&P ...

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

Joe Biden's "Inflation Reduction Act" didn't bring down prices – but it is poised to reduce the size of North Carolina's ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

If prescription savings are to be passed on to Americans not on Medicare, Congress likely would have to pass a law to enact ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

Is there anyone who thinks prescription drug prices in America are about right? President Trump has elevated an issue ...

S&P 500 pharma stocks hold firm despite Trump’s drug pricing threat. Is Merck a put-selling opportunity amid headline noise?